Blue Star Ltd Q2 FY2026 Concall Summary

Key Takeaways

• A rain-interrupted quarter, full-year reset to flat: Revenue grew just 6.4% as a failed summer, GST disruption and unseasonal rain wiped out peak-season demand, forcing management to cut its full-year growth outlook from +5% to a range of –15% to 0.
• Margins held up despite the top-line shock: EBITDA margin improved to 7.6% (from 6.6% YoY) as a richer project mix in Segment-I and aggressive cost-cutting in Unitary Products offset the volume hit.
• The projects business is flashing a serious caution light: Enquiry inflows are lower, order finalizations are taking time, and existing infra-projects are running longer than estimated, so the company is prioritising margins and cash flow over market share.
• Inventory overhang is the make-or-break variable for FY26: Channel and brand inventory sits at 60–65 days against a winter norm of 45 days, and it must be liquidated before the January 1 energy-label change triggers a production switch.
• What to watch next quarter: Whether the December and late-February demand windows clear the inventory pile, the pace of order inflow recovery in Electro-Mechanical Projects, and any clarity on the MedTech refurbished-equipment policy.

The Quarter That Broke the Year

• Summer failed, then GST hit, then rain: The summer season was already impacted through July, and the August 15 GST rate-cut announcement froze Room AC and some Commercial AC demand from mid-August to September 22. Just as secondary sales picked up to 35% between September 22 and Diwali, unseasonal rain and disruptions killed the festival season.
• Room AC volumes fell less than the industry: Industry volumes are estimated to have shrunk ~17% in Q2, while Blue Star declined ~12%; for H1, the industry is down ~15% and Blue Star ~10%. Management attributes the gap to a high prior-year base, not a structural share shift.
• Commercial Refrigeration grew through the noise: The segment delivered ~7–8% growth despite regulatory changes from the prior year (BIS norms on water coolers and deep freezers) now being behind it.
• Segment-III de-growth was policy-driven, not demand-driven: The 20.1% revenue drop came almost entirely from the MedTech solutions business, where the regulatory framework for refurbished diagnostic equipment remains unresolved.
• Inventory is the number that now defines the year: Post-summer inventory did not liquidate during the festival season, leaving 60–65 days of combined brand and channel stock. That stock must clear before summer, and new energy-label-compliant production must begin from January 1.

Thiagarajan: "So overall, it is a rain-interrupted match. As I keep telling, it is all Duckworth-Lewis method. We do not know how many overs are left or what is the asking rate, so rain keeps interrupting on one side."

Margin Resilience & the Cost Levers

• Segment-I margin expanded on mix, not volume: Margins rose to 8.8% from 8.3% YoY because manufacturing and data-center projects, which carry better margins, grew their share of the segment. Infrastructure project margins remain lower, and the company is not chasing that business.
• Segment-II held margins flat on aggressive cost action: Despite a 9.5% revenue decline, Unitary Products margins came in at 6.2% versus 7% a year ago. The company cut advertising, pulled back in-shop demonstrators, drove manufacturing cost reduction and negotiated vendor discounts.
• Marketing spend will be re-engineered for a weather-volatile world: Management acknowledged that IPL advertising was committed in advance on the assumption of a normal summer, and that the marketing-expense mix must change substantially going forward.
• Cash-flow swung to borrowing on inventory and capex: The net cash position moved to net borrowing because the prior year benefited from QIP cash, exceptional sales with good accruals and minimal working capital, while this year carries inventory buildup and capex.

Thiagarajan: "I think we should be very happy if we end the year anywhere between 7% to 7.5%. We will work towards 7.5%, it can well be 7%. It all depends now on that February second half, March and the inventory have to move out before the energy label change."

Electro-Mechanical Projects: A Serious Caution

• Enquiry inflows are lower and order finalizations are taking time: Management described the caution as "serious, not slight," pointing to a broad slowdown in enquiry generation and delayed decision-making across several segments.
• Existing infra-projects are stretching out: Projects already in the book are taking much longer than originally estimated, tying up working capital and delaying revenue recognition.
• The response is margin-over-volume discipline: The company is explicitly not chasing market share in this environment, focusing instead on protecting margins and cash flow.
• Data-center chillers are in development, not yet commercial: Some chillers exist, others are being developed, and liquid-cooling partnerships are being explored, but high-tech products requiring field trials will not launch before the end of this financial year.

Thiagarajan: "No, it is not a slight caution, it is a serious caution. In the sense, look, for me, the enquiry inflow will indicate order finalization trend. Now, enquiry inflows are lower, and order finalizations are taking time in quite a few segments."

The Energy-Label Transition: Risk and Opportunity

• The January 1 deadline resets the product line: New 5-Star ACs produced after December 31 will carry higher energy efficiency and a 7–10% price increase. Manufacturers must either produce new products or re-label existing ones from that date.
• A pre-transition demand window opens in December: A couple of weeks of buying is expected before the label change, followed by the last few days of February and March as the main summer-demand window.
• Inventory liquidation is the top priority from January 1: Both channel and manufacturer inventory must be cleared before summer, because new-label production cannot begin until old stock moves. The 60–65 days of inventory on hand makes this the single largest swing factor for the full year.
• Domestic manufacturing gives flexibility that imports never did: Because production is now largely domestic, the company can curtail output in response to demand signals, unlike the earlier import-dependent model where material would already have arrived.

International, Industrial Systems & MedTech

• US supply is scaling after trial marketing: With the approval process and trial marketing completed for a few products, supply scaled in Q1 and Q2 FY26. Product development for both the US and European markets is now complete.
• India-US trade deal is the next catalyst: International business is expected to accelerate once the trade deal is concluded, though tariff-related uncertainties persist in the interim.
• Industrial Systems is a steady 10–12% CAGR story: The business grows with manufacturing investments and GDP, and management sees that trajectory as durable.
• MedTech is a policy-shaped black box: The regulatory framework for refurbished medical diagnostic equipment, including MRI and CT scanners, is in the making, with a "Make in India" requirement and unknown rules for refurbished machines. Management is explicit that it has no visibility on how the policy will pan out.

Thiagarajan: "We are not sure at all that how this policy will pan out. There is one make in India requirement, refurbished machines that obviously will have to be regulated. In what form it will be regulated, we do not know. So to that extent, there is uncertainty out there."

Guidance & Commitments

Key Metrics